SALT LAKE CITY--(BUSINESS WIRE)--Tolero Pharmaceuticals, Inc., a late stage pharmaceutical company developing treatments for serious hematological diseases, today announced the upcoming scientific presentations of alvocidib at the Society of Hematologic Oncology SOHO 2015 Annual Meeting in Houston, Texas, taking place September 16 through 19, and the 2015 American Society of Hematology (ASH) Meeting on Hematology and Malignancies in Chicago, taking place September 17 through 19.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
